AMIA submitted comments on CMS’s proposed drug prior authorization rule, supporting FHIR-based interoperability and electronic prior authorization modernization. AMIA urged CMS to reduce administrative burden, improve medication access, strengthen transparency and standards alignment, enhance API performance and patient access, establish safeguards for AI-enabled prior authorization, and advance long-term prior authorization […]
AMIA’s comments on the NIH FY27–FY31 Strategic Plan framework urge NIH to prioritize informatics, data science, artificial intelligence, and digital infrastructure as foundational enablers of biomedical research. AMIA recommends strengthening workforce development, modernizing research data resources, advancing interoperable and trustworthy health technologies, and promoting transparent, evidence-based research stewardship. The comments […]